Evidence Synthesis for Decision Making in Healthcare (eBook)

Nicky Welton, Department of Social Medicine, University of Bristol Dr Welton's research includes Bayesian statistical modeling in epidemiology and evidence synthesis and evidence consistency. Alex Sutton, Department of Health Sciences, University of Leicester Dr Sutton, senior lecture in medical statistics, has a primary research interest in meta-analysis. This specifically includes methods to combine evidence from disparate sources, and methods to deal with the problem of publication bias. With numerous published papers in a variety of journals he has also collaborated on over 15 substantive evidence synthesis projects. He is lead author on one of the first textbooks on meta-analysis in medicine and is co-editor on a recently published Wiley book on publication bias. Nicola Cooper, Department of Health Sciences, University of Leicester Dr Cooper's primary research interest is in the interface and integration of medical statistics and health economics. This specifically includes methods for statistical modelling of cost data, integration of evidence synthesis within a decision-modelling context, handling of missing data in economic evaluations conducted alongside clinical trials, and the application of Bayesian statistical methods to all of the above. Keith Abrams, Department of Health Sciences, University of Leicester Professor Abrams' research interests include the development and application of Bayesian methods in healthcare evaluation, systematic reviews and meta-analysis, and the joint modeling of longitudinal and time-to-event data. He has published dozens of articles in numerous international journals and is the co-author of two Wiley books in this area. Anthony E Ades, Department of Social Medicine, University of Bristol with over 30 published articles in the last three years, Professor Ades' research interests include statistical methods for multi-parameter evidence synthesis in epidemiology, disease mapping and economic evaluation; Bayesian decision theory and the expected value of information; statistical and epidemiological methods in infectious disease surveillance.

Preface

1. INTRODUCTION

1.1. The rise of health economics

1.2. Decision-making under uncertainty

1.3. Evidence-based medicine

1.4. Bayesian statistics

1.5. NICE

1.6. About this book

1.7. Summary key points

1.8. Further reading

2. BAYESIAN METHODS AND WINBUGS

2.1. Introduction to Bayesian methods

2.2. Introduction to WinBUGS

2.3. Advantages and disadvantages of a Bayesian approach

2.4. Summary key points

2.5. Further reading

2.6. Exercises

3. INTRODUCTION TO DECISION MODELS

3.1. Introduction

3.2. Decision tree models

3.3. Model parameters

3.4. Deterministic decision tree

3.5. Stochastic decision tree

3.6. Sources of evidence

3.7. Principles of synthesis for decision models (motivation for the rest of the book)

3.8. Summary key points

3.9. Further reading

3.10. Exercises

4. META-ANALYSIS USING BAYESIAN METHODS

4.1. Introduction

4.2. Fixed effect model

4.3. Random effects model

4.4. Publication bias

4.5. Study validity

4.6. Summary key points

4.7. Further reading

4.8. Exercises

5. EXPLORING BETWEEN STUDY HETEROGENEITY

5.1. Introduction

5.2. Random effects meta-regression models

5.3. Limitations of meta-regression

5.4. Baseline risk

5.5. Summary key points

5.6. Further reading

5.7. Exercises

6. MODEL CRITIQUE AND EVIDENCE CONSISTENCY IN RANDOM EFFECTS META-ANALYSIS

6.1. Introduction

6.2. The random effects model revisited

6.3. Assessing model fit

6.4. Model comparison

6.5. Exploring inconsistency

6.6. Summary key points

6.7. Further reading

6.8. Exercises

7. EVIDENCE SYNTHESIS IN A DECISION MODELLING FRAMEWORK

7.1. Introduction

7.2. Evaluation of decision models: one-stage vs two-stage

7.3. Sensitivity analyses (of model inputs and model specifications)

7.4. Summary key points

7.5. Further reading

7.6. Exercises

8. MULTI-PARAMETER EVIDENCE SYNTHESIS IN EPIDEMIOLOGICAL MODELS

8.1. Introduction

8.2. Prior and posterior simulation in a probabilistic model: maple syrup urine disease - MSUD

8.3. A model for prenatal HIV testing

8.4. Model criticism in multi-parameter models

8.5. Evidence-based policy

8.6. Summary key points

8.7. Further reading

8.8. Exercises

9. MIXED TREATMENT COMPARISONS

9.1. Why go beyond "direct" head-to-head trials?

9.2. A fixed treatment effect model for MTC

9.3. Random effect MTC models

9.4. Model choice and consistency of MTC evidence

9.5. Multi-arm trials

9.6. Assumptions made in MTC

9.7. Embedding an MTC within a cost-effectiveness analysis

9.8. Extension to continuous, rate and other outcomes

9.9. Key points

9.10. Further reading

9.11. Exercises

10. MARKOV MODELS

10.1. Introduction

10.2. Continuous and discrete time Markov models

10.3. Decision analysis with Markov models

10.4. Estimating transition parameters from a single study

10.5. Propagating uncertainty in Markov parameters into a decision model

10.6. Estimating transition parameters from a synthesis of several studies

10.7. Summary key points

10.8. Further reading

10.9. Exercises

11. GENERALISED EVIDENCE SYNTHESIS

11.1. Introduction

11.2. Deriving a prior distribution from observational evidence

11.3. Bias allowance model for the observational data

11.4. Hierarchical models for evidence from different study designs

11.5. Discussion

11.6. Summary key points

11.7. Further reading

11.8. Exercises

12. EXPECTED VALUE OF INFORMATION FOR RESEARCH PRIORITISATION AND STUDY DESIGN

12.1. Introduction

12.2. Expected value of perfect information

12.3. Expected value of partial perfect information

12.4. Expected value of sample information

12.5. Expected net benefit of sampling

12.6. Summary key points

12.7. Further reading

12.8. Exercises

APPENDICES

Appendix A1: Abbreviations

Appendix A2: Common Distributions

NOMENCLATURE/NOTATION

Index